According to well being consultants, more than 50% of Bangkok’s inhabitants are fatties and consider there is a pressing need to address the well being of lard-arsed residents not solely in the capital but all through the Kingdom of Thailand.
Fortunately, there are individuals out there who care and wish to prevent the fats people of Bangkok, and Thailand, from getting fatter and dying due to being obese.
The Thai NCDs Network Association, in collaboration with Novo Nordisk Pharma (Thailand) Co., Ltd., hosted a seminar titled OBESITY: A Public Health Crisis on the Thai Annual Conference NCD Alliance 2023, which centred on the theme Fighting the Obesity Pandemic. The event was attended by medical professionals from everywhere in the nation and happened at the True Icon Hall, Icon Siam in Bangkok, reported Bangkok Post
During the seminar, members discussed various aspects of the obesity crisis, together with the monetary burden that the government must bear. The urgency of addressing this concern in all sectors has prompted the necessity for policies aimed toward preventing obesity, as well as clear and effective remedy tips to address the needs of this affected person population.
Obesity is a important well being concern that requires quick attention because of its association with over 200 other serious problems, together with diabetes, hypertension, extra body fats, heart illness, dementia, and others. Unfortunately, obesity rates in Thailand continue to rise.
According to a survey performed in 2020, the prevalence of weight problems has reached alarming levels, with charges as high as 42%, and even higher in Bangkok at 56%.
In comparability, the relaxation of Thailand has an weight problems price of 50%. If left unchecked, this pattern will have a significant impression on public health. Therefore, it’s essential for the public and private sectors to work collectively to search out methods to prevent and address the obesity disaster.
Enrico Cañal Bruland, Vice President & General Manager of Novo Nordisk Pharma (Thailand) Co., Ltd., stated Novo is dedicated to driving change for people dwelling with obesity in Thailand.
“We have invested considerably in research and growth, including local research right here in Thailand, and we have accelerated entry to our innovative medicines for people residing with weight problems.”
Prof Wannee Nitiyanant, President of the Diabetes Association of Thailand, reported that the price burden of weight problems is huge, with a tremendous monetary influence on society.
“In Thailand, this case requires urgent action to tackle this disease and the time to behave is now. The sustainability of the Thai healthcare system is determined by our success in curbing this obesity crisis, in any other case, the system will soon be overwhelmed by the exponential trajectory of direct and indirect costs.
“For Thailand, the general healthcare spending sits at 6.6% of GDP, while 1.5% of GDP is dedicated to weight problems and its associated problems. If we don’t act, this quantity alone will rise to six.4% of GDP primarily based on latest knowledge. This will definitely have an result on everybody in our generation right here in Thailand.”
Light decided that the population of Bangkok, when it comes to weight problems, is about 5.5 million people. Among people aged 20-69 with a physique mass index (BMI) between 30 and 50, there are about 356,000 individuals who, in the event that they lose 10% of their weight over the following decade, might save up to 2 billion baht on medical expenses.
The authorities, via the Centers for Disease Control, has taken steps to manage obesity within the healthcare system through the “NCD Clinic Plus” program, which handles weight control in sufferers with underlying ailments, and has established workplace policies and methods to encourage government agencies and private organizations to have good well being policies for their staff. Additionally, there’s a push for the implementation of “NCD Clinic Plus” in sub-district hospitals for well being promotion, in addition to in quite a few other sectors.
Currently, weight problems surgical procedure can be reimbursed (depending on medical remedy rights) for sufferers with a BMI of 37.5 (without comorbidities) or 32.5+ with a quantity of comorbidities. However, there are at present no clear standards for the reimbursement of obesity medicine.
If the long-term results of obesity on each patients and the economy are thought-about, having clear guidelines and necessities for the remedy of obesity will result within the biggest future benefit when it comes to reimbursement of medical expenses for overweight sufferers by way of the “always cost mechanism associated to medical service.”
Therefore, clear native remedy tips and studies on the health-economic worth (cost-effectiveness) of treating sufferers (such as behaviour modification or medication for weight problems treatment) are crucial for further considerations beyond surgical procedure..